EP2680826 - VITAMIN D COMPOSITION [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.06.2018 Database last updated on 19.10.2024 | |
Former | The patent has been granted Status updated on 21.07.2017 | ||
Former | Grant of patent is intended Status updated on 23.04.2017 | Most recent event Tooltip | 17.07.2020 | Lapse of the patent in a contracting state New state(s): AL | published on 19.08.2020 [2020/34] | Applicant(s) | For all designated states D3 Pharma Limited Onega House 112 Main Road Sidcup Kent DA14 6NE / GB | [2014/02] | Inventor(s) | 01 /
HUATAN, Hiep D3 Pharma Limited Onega House 112 Main Road Sidcup Kent DA14 6NE / GB | [2014/02] | Representative(s) | Docherty, Robert Charles, et al Symbiosis IP Limited York Biotech Campus Office 14FA05 Sand Hutton York, YO41 1LZ / GB | [N/P] |
Former [2017/34] | Docherty, Robert Charles, et al Symbiosis IP Limited NAFIC Office 14FA05 Sand Hutton York, North Yorkshire YO41 1LZ / GB | ||
Former [2014/02] | Docherty, Robert Charles Symbiosis IP Limited Apollo House Eboracum Way Heworth Green, York YO31 7RE / GB | Application number, filing date | 12712144.0 | 27.02.2012 | [2017/34] | WO2012GB50434 | Priority number, date | GB20110003519 | 02.03.2011 Original published format: GB 201103519 | GB20110008393 | 19.05.2011 Original published format: GB 201108393 | [2014/02] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012117236 | Date: | 07.09.2012 | Language: | EN | [2012/36] | Type: | A1 Application with search report | No.: | EP2680826 | Date: | 08.01.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.09.2012 takes the place of the publication of the European patent application. | [2014/02] | Type: | B1 Patent specification | No.: | EP2680826 | Date: | 23.08.2017 | Language: | EN | [2017/34] | Search report(s) | International search report - published on: | EP | 07.09.2012 | Classification | IPC: | A61K9/48, A61K31/593, A61P3/02 | [2014/02] | CPC: |
A61K9/4858 (EP,GB);
A61K31/593 (EP,GB);
A61P19/10 (EP);
A61P3/02 (EP)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2015/13] |
Former [2014/02] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Title | German: | VITAMIN D ZUSAMMENSETZUNG | [2017/18] | English: | VITAMIN D COMPOSITION | [2014/02] | French: | COMPOSITION DE VITAMINE D | [2014/02] |
Former [2014/02] | VITAMIN-D-ZUSAMMENSETZUNG | Entry into regional phase | 09.09.2013 | National basic fee paid | 09.09.2013 | Designation fee(s) paid | 09.09.2013 | Examination fee paid | Examination procedure | 09.09.2013 | Amendment by applicant (claims and/or description) | 09.09.2013 | Examination requested [2014/02] | 23.06.2014 | Despatch of a communication from the examining division (Time limit: M06) | 03.11.2014 | Reply to a communication from the examining division | 11.03.2016 | Observations by third parties | 16.06.2016 | Despatch of a communication from the examining division (Time limit: M04) | 27.07.2016 | Reply to a communication from the examining division | 24.04.2017 | Communication of intention to grant the patent | 12.07.2017 | Fee for grant paid | 12.07.2017 | Fee for publishing/printing paid | 12.07.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 23.06.2014 | Opposition(s) | 24.05.2018 | No opposition filed within time limit [2018/31] | Fees paid | Renewal fee | 10.01.2014 | Renewal fee patent year 03 | 08.01.2015 | Renewal fee patent year 04 | 21.12.2015 | Renewal fee patent year 05 | 23.01.2017 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 27.02.2012 | AL | 23.08.2017 | AT | 23.08.2017 | CY | 23.08.2017 | CZ | 23.08.2017 | EE | 23.08.2017 | HR | 23.08.2017 | LT | 23.08.2017 | LV | 23.08.2017 | MC | 23.08.2017 | MK | 23.08.2017 | PL | 23.08.2017 | PT | 23.08.2017 | RO | 23.08.2017 | RS | 23.08.2017 | SI | 23.08.2017 | SK | 23.08.2017 | SM | 23.08.2017 | TR | 23.08.2017 | BG | 23.11.2017 | NO | 23.11.2017 | GR | 24.11.2017 | IS | 23.12.2017 | LU | 27.02.2018 | MT | 27.02.2018 | CH | 28.02.2018 | LI | 28.02.2018 | [2020/34] |
Former [2020/31] | HU | 27.02.2012 | |
AT | 23.08.2017 | ||
CY | 23.08.2017 | ||
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
MK | 23.08.2017 | ||
PL | 23.08.2017 | ||
PT | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
TR | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
LU | 27.02.2018 | ||
MT | 27.02.2018 | ||
CH | 28.02.2018 | ||
LI | 28.02.2018 | ||
Former [2020/27] | HU | 27.02.2012 | |
AT | 23.08.2017 | ||
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
PL | 23.08.2017 | ||
PT | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
TR | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
LU | 27.02.2018 | ||
MT | 27.02.2018 | ||
CH | 28.02.2018 | ||
LI | 28.02.2018 | ||
Former [2020/16] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
TR | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
LU | 27.02.2018 | ||
MT | 27.02.2018 | ||
CH | 28.02.2018 | ||
LI | 28.02.2018 | ||
Former [2020/08] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
LU | 27.02.2018 | ||
MT | 27.02.2018 | ||
CH | 28.02.2018 | ||
LI | 28.02.2018 | ||
Former [2018/52] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
LU | 27.02.2018 | ||
CH | 28.02.2018 | ||
LI | 28.02.2018 | ||
Former [2018/44] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
MC | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/39] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SI | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/24] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SK | 23.08.2017 | ||
SM | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/23] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
EE | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
PL | 23.08.2017 | ||
RO | 23.08.2017 | ||
RS | 23.08.2017 | ||
SK | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/21] | AT | 23.08.2017 | |
CZ | 23.08.2017 | ||
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
PL | 23.08.2017 | ||
RS | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/12] | AT | 23.08.2017 | |
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
LV | 23.08.2017 | ||
PL | 23.08.2017 | ||
RS | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/11] | AT | 23.08.2017 | |
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
PL | 23.08.2017 | ||
RS | 23.08.2017 | ||
BG | 23.11.2017 | ||
NO | 23.11.2017 | ||
GR | 24.11.2017 | ||
IS | 23.12.2017 | ||
Former [2018/10] | AT | 23.08.2017 | |
HR | 23.08.2017 | ||
LT | 23.08.2017 | ||
RS | 23.08.2017 | ||
NO | 23.11.2017 | ||
Former [2018/07] | LT | 23.08.2017 | |
NO | 23.11.2017 | Cited in | International search | [XI]WO03059358 (ROCHE VITAMINS AG [CH], et al); | [Y]WO2006116204 (NOVACEA INC [US], et al); | [Y]WO2008134512 (CYTOCHROMA INC [CA], et al); | [XI]WO2010111397 (ADDS PHARMACEUTICALS LLC [US], et al); | by applicant | US2003191093 | WO2009009134 | US2009196862 | WO2009098295 |